author-photo

Hanno Wild

Bayer

48

Papers

331

Citations

Citation Trend

Filter By

Papers (38) Sort By

Journal Conference Others

Abstract 850: Mesothelin targeted thorium-227 conjugate (MSLN-TTC): Preclinical evaluation of a new targeted alpha therapeutic in mesothelin-positive cancers

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 855: Increased in vitro potency and in vivo efficacy of FGFR2-targeted thorium-227 conjugate (FGFR2-TTC) in combination with the ATR inhibitor BAY 1895344

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 849: Synergistic effect of MSLN-TTC in combination with DNA damage response inhibitors

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5199: Preclinical activity of the FGFR2-targeted thorium-227 conjugate in preclinical models of colorectal, gastric and triple-negative breast cancer

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Dihidropirazolonas substituted and their use as inhibitors of HIF prolyl 4-hydroxylase

2007
Show All
- Source
- Cite
- Save
Citations (0)
Substituierte dihydropyrazolone und ihre verwendung als hif-prolyl-4 -hydroxylase inhibitoren

2007
Show All
- Source
- Cite
- Save
Citations (0)
Substituierte dipyridyl-dihydropyrazolone und ihre verwendung

2007
Show All
- Source
- Cite
- Save
Citations (0)
p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

2001 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (40)
Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.

2001 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (78)
Neue, substituierte Isoxazoline

1999
Show All
- Source
- Cite
- Save
Citations (0)